<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New anti-epileptic from Boehringer</title><link>/b/veterinary-news/posts/87171</link><description> Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy. 
 Canine epilepsy can affect up to 5% of dogs 6 . In most dogs diagnosed with idiopathic epilepsy no
underlying cause for the seizures</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>